Atlas Trials

A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy

Clinical trial NCT03473639 · COMPLETED

Trial details

NCT number
NCT03473639
Sponsor
University of Virginia
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast CancerBreast Cancer
Start date
2019-01-29
Primary completion
2021-09-02
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.